-
Innovation Ranking
NewInnovation Ranking – KT Corp
KT Corp (KT Corp) is a provider of telecommunication and internet services that offers integrated wired and wireless communication services. KT Corp yields interconnection services to other telecommunications companies, broadband Internet access service, and IPTV services. It offers a wide range of leased line services, satellite service and information technology, satellite TV service, media contents business, cloud computing services and other data communication services. The company also provides credit card processing and other financial services, real estate business and automobile...
-
Innovation Ranking
NewInnovation Ranking – KT&G Corp
KT&G Corp (KT&G) produces, distributes and sells tobacco, ginseng, health food, cosmetics and pharmaceuticals products. The company’s products portfolio consists of red ginseng, food and beverages, over-the-counter medicines and medical supplies and equipment’s. It also distributes materials related to tobacco business. KT&G markets these products under various brands including, Esse, Carnival, Bohem, Raison, This, Tonino Lamborghini, Time, and Pine. _x000D_ It is also involved in real estate, rental and house development business, leaf tobacco cultivation and trading related activities. The...
-
Product Insights
NewNet Present Value Model: Kymera Therapeutics Inc’s KT-333
Empower your strategies with our Net Present Value Model: Kymera Therapeutics Inc's KT-333 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KT-474 in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-474 in Hidradenitis Suppurativa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-474 in Hidradenitis Suppurativa Drug Details: KT-474 (KYM-001) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KT-333 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-333 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-333 in Solid Tumor Drug Details: KT-333 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KT-333 in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-333 in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-333 in Non-Hodgkin Lymphoma Drug Details: KT-333 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KT-333 in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-333 in Head And Neck Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-333 in Head And Neck Cancer Drug Details: KT-333...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KT-333 in T-Cell Lymphomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-333 in T-Cell Lymphomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-333 in T-Cell Lymphomas Drug Details: KT-333 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KT-333 in Cutaneous T-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-333 in Cutaneous T-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-333 in Cutaneous T-Cell Lymphoma Drug Details: KT-333 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KT-474 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KT-474 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KT-474 in Atopic Dermatitis (Atopic Eczema) Drug Details: KT-474 (KYM-001)...